Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barbacid

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Hybridoma|February 1, 1991
Generation of monoclonal antibodies specific for ras p21 Glu-12 oncoproteins: detection in carcinogen-induced mammary carcinomasD S Garlick, S Sukumar, M Barbacid, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 16, 1998
TrkB and TrkC signaling are required for maturation and synaptogenesis of hippocampal connectionsA Martínez, S Alcántara, V Borrell, et al.
The Journal of Biological Chemistry|November 5, 1997
Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3S Mañes, E Mira, M M Barbacid, et al.
The Journal of Antibiotics|April 1, 1992
10'-Desmethoxystreptonigrin, a novel analog of streptonigrinW C Liu, M Barbacid, M Bulgar, et al.
Oncogene|May 18, 1995
Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformationJ M Carboni, N Yan, A D Cox, et al.
Molecular and Cellular Biology|April 5, 2001
Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d)F Zindy, W den Besten, B Chen, et al.
Developmental Biology|October 23, 1997
Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFRB T Fundin, I Silos-Santiago, P Ernfors, et al.
Journal of Medicinal Chemistry|February 3, 1995
Phosphinyl acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferaseD V Patel, E M Gordon, R J Schmidt, et al.
Oncogene|October 20, 2010
Upregulation of miR-21 by Ras in vivo and its role in tumor growthD Frezzetti, M De Menna, P Zoppoli, et al.
Current Biology : CB|May 28, 1998
Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptorK D Fischer, Y Y Kong, H Nishina, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Hybridoma|February 1, 1991
Generation of monoclonal antibodies specific for ras p21 Glu-12 oncoproteins: detection in carcinogen-induced mammary carcinomasD S Garlick, S Sukumar, M Barbacid, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 16, 1998
TrkB and TrkC signaling are required for maturation and synaptogenesis of hippocampal connectionsA Martínez, S Alcántara, V Borrell, et al.
The Journal of Biological Chemistry|November 5, 1997
Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3S Mañes, E Mira, M M Barbacid, et al.
The Journal of Antibiotics|April 1, 1992
10'-Desmethoxystreptonigrin, a novel analog of streptonigrinW C Liu, M Barbacid, M Bulgar, et al.
Oncogene|May 18, 1995
Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformationJ M Carboni, N Yan, A D Cox, et al.
Molecular and Cellular Biology|April 5, 2001
Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d)F Zindy, W den Besten, B Chen, et al.
Developmental Biology|October 23, 1997
Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFRB T Fundin, I Silos-Santiago, P Ernfors, et al.
Journal of Medicinal Chemistry|February 3, 1995
Phosphinyl acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferaseD V Patel, E M Gordon, R J Schmidt, et al.
Oncogene|October 20, 2010
Upregulation of miR-21 by Ras in vivo and its role in tumor growthD Frezzetti, M De Menna, P Zoppoli, et al.
Current Biology : CB|May 28, 1998
Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptorK D Fischer, Y Y Kong, H Nishina, et al.
Pageof 19